Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
9,835
+256
+3% +$29.6K 0.18% 84
2025
Q4
$1.01M Sell
9,579
-21
-0.2% -$1.97K 0.15% 108
2025
Q3
$806K Sell
9,600
-16
-0.2% -$1.32K 0.13% 109
2025
Q2
$761K Buy
9,616
+89
+0.9% +$7.07K 0.13% 109
2025
Q1
$855K Buy
9,527
+117
+1% +$10.9K 0.16% 95
2024
Q4
$936K Buy
9,410
+96
+1% +$9.9K 0.19% 83
2024
Q3
$1.06M Buy
9,314
+103
+1% +$12.2K 0.25% 64
2024
Q2
$1.14M Sell
9,211
-1,088
-11% -$140K 0.28% 64
2024
Q1
$1.36M Sell
10,299
-518
-5% -$63.8K 0.33% 58
2023
Q4
$1.18M Buy
10,817
+133
+1% +$13.8K 0.3% 61
2023
Q3
$1.1M Buy
10,684
+57
+0.5% +$6.14K 0.42% 41
2023
Q2
$1.23M Buy
10,627
+54
+0.5% +$6.13K 0.44% 41
2023
Q1
$1.12M Sell
10,573
-1,969
-16% -$213K 0.43% 40
2022
Q4
$1.39M Buy
12,542
+376
+3% +$38.4K 0.57% 30
2022
Q3
$1.05M Buy
12,166
+8,419
+225% +$752K 0.47% 38
2022
Q2
$342K Buy
+3,747
New +$332K 0.15% 95

Other funds holding MRK

Round Rock Advisors's MRK Position: Q1 2026 in Review

Round Rock Advisors increased its Merck (MRK) stake by 2.7% in Q1 2026, buying an estimated $29.6K and bringing the position to 9,835 shares worth $1.18M. The position accounts for 0.18% of the portfolio, ranked #84.

Round Rock Advisors first reported a position in MRK in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.39M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Round Rock Advisors held 9,835 shares of Merck worth $1.18M as of Q1 2026.
  • Round Rock Advisors bought 256 Merck shares in Q1 2026, an estimated $29.6K.
  • Merck made up 0.18% of Round Rock Advisors's portfolio in Q1 2026, its #84 holding.
  • Round Rock Advisors first reported a position in Merck in Q2 2022 and has held it in 16 quarters since.
  • Round Rock Advisors's Merck position peaked at $1.39M in Q4 2022.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Round Rock Advisors's 13F filing for Q1 2026, filed 15 May 2026.